Globus Medical Inc (GMED)
84.91
+1.32
(+1.58%)
USD |
NYSE |
Nov 21, 16:00
84.88
-0.03
(-0.04%)
After-Hours: 20:00
Globus Medical Revenue (Quarterly): 625.70M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 625.70M |
| June 30, 2024 | 629.69M |
| March 31, 2024 | 606.67M |
| December 31, 2023 | 616.53M |
| September 30, 2023 | 383.64M |
| June 30, 2023 | 291.62M |
| March 31, 2023 | 276.69M |
| December 31, 2022 | 274.50M |
| September 30, 2022 | 254.15M |
| June 30, 2022 | 263.65M |
| March 31, 2022 | 230.55M |
| December 31, 2021 | 250.02M |
| September 30, 2021 | 229.72M |
| June 30, 2021 | 251.02M |
| March 31, 2021 | 227.34M |
| December 31, 2020 | 233.44M |
| September 30, 2020 | 216.10M |
| June 30, 2020 | 148.92M |
| March 31, 2020 | 190.58M |
| December 31, 2019 | 211.67M |
| September 30, 2019 | 196.22M |
| June 30, 2019 | 194.54M |
| March 31, 2019 | 182.95M |
| December 31, 2018 | 195.94M |
| September 30, 2018 | 169.24M |
| Date | Value |
|---|---|
| June 30, 2018 | 173.38M |
| March 31, 2018 | 174.41M |
| December 31, 2017 | 176.03M |
| September 30, 2017 | 151.74M |
| June 30, 2017 | 152.39M |
| March 31, 2017 | 155.81M |
| December 31, 2016 | 151.59M |
| September 30, 2016 | 135.65M |
| June 30, 2016 | 137.49M |
| March 31, 2016 | 139.26M |
| December 31, 2015 | 142.59M |
| September 30, 2015 | 136.99M |
| June 30, 2015 | 133.57M |
| March 31, 2015 | 131.60M |
| December 31, 2014 | 128.80M |
| September 30, 2014 | 117.79M |
| June 30, 2014 | 113.57M |
| March 31, 2014 | 114.21M |
| December 31, 2013 | 115.24M |
| September 30, 2013 | 107.19M |
| June 30, 2013 | 107.01M |
| March 31, 2013 | 105.02M |
| December 31, 2012 | 100.54M |
| September 30, 2012 | 94.76M |
| June 30, 2012 | 95.98M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
148.92M
Minimum
Jun 2020
629.69M
Maximum
Jun 2024
320.61M
Average
252.58M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| ResMed Inc | 1.225B |
| Haemonetics Corp | 345.51M |
| Abbott Laboratories | 10.64B |
| Stryker Corp | 5.494B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 51.84M |
| Total Expenses (Quarterly) | 576.71M |
| EPS Diluted (Quarterly) | 0.38 |
| Enterprise Value | 11.30B |
| Gross Profit Margin (Quarterly) | 56.77% |
| Profit Margin (Quarterly) | 8.28% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 1.45% |
| Normalized Earnings Yield | 1.050 |